Naprotin

PureTek Corporation🇺🇸 United States

FDA Page

Effective Date: Sep 27, 2022
Approval ID: dc2d2783-2a73-cb7c-e053-2995a90a9961
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

Naprotin Kit These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976

Quick Stats

Total Products1

Labelers2

Label Sections29

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.